2023 SEC Examination Priorities for Investment Advisers | Dorsey ... - JD Supra

1 min to read

2023 SEC Examination Priorities for Investment Advisers | Dorsey … – JD Supra

Nasdaq Updates Listing Requirements

Throughout 2024, Nasdaq has been revising the procedures for companies dealing with low stock prices, with a focus on cutting...
S-4 – Akari Therapeutics Plc (0001541157) (Filer)

Filed: 2024-09-13 AccNo: 0001193125-24-218968 Size: 28 MB Source: S-4 - Akari Therapeutics Plc (0001541157) (Filer)
S-4 – Blue Owl Finance LLC (0002012650) (Filer)

Filed: 2024-09-10 AccNo: 0001193125-24-216704 Size: 5 MB Source: S-4 - Blue Owl Finance LLC (0002012650) (Filer)
S-4 – Blue Owl GP Stakes GP Holdings LLC (0002012652) (Filer)

Filed: 2024-09-10 AccNo: 0001193125-24-216704 Size: 5 MB Source: S-4 - Blue Owl GP Stakes GP Holdings LLC (0002012652) (Filer)
S-1MEF – Bicara Therapeutics Inc. (0002023658) (Filer)

Filed: 2024-09-12 AccNo: 0001193125-24-218205 Size: 64 KB Source: S-1MEF - Bicara Therapeutics Inc. (0002023658) (Filer)